Peppermint Charité Beteiligungsfonds

Peppermint Charité Beteiligungsfonds is a venture capital firm specializing in investments within the healthcare and life sciences sectors. The firm focuses on early-stage companies that have demonstrated proof-of-concept for their technologies, products, or services. By leveraging its collaboration with Charité – Universitätsmedizin Berlin, one of Europe's largest medical schools, the fund gains privileged access to a vast network and deal flow, facilitating the evaluation and support of promising healthcare innovations.

The fund's investment strategy encompasses a broad spectrum of stages, including seed, Series A, Series B, growth, and late-stage financing. It primarily targets companies operating in Germany and Europe, aiming to foster the development and commercialization of innovative healthcare solutions. The fund's portfolio spans various industries within the healthcare and life sciences domains, such as MedTech, digital health, pharmaceuticals, biotechnology, diagnostics, medical devices, health IT, biopharmaceuticals, medical research, clinical trials, health services, medical equipment, and health technology.

Peppermint Charité Beteiligungsfonds has a history of successful investments, including its involvement in the Charité Biomedical Fund, which has supported companies like Humedics GmbH and CryoTherapeutics GmbH. These investments underscore the fund's commitment to advancing medical technologies and improving patient care through strategic partnerships and financial support.